Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Kinetics of the functional loss of different muscarinic receptor isoforms in Xenopus oocytes.
Matus-Leibovitch N
,
Mengod G
,
Oron Y
.
???displayArticle.abstract???
Native Xenopus oocytes express two isoforms of muscarinic receptors that mediate qualitatively different physiological responses. Oocytes of the majority of donors (common) express M3-like receptors (M3Rs) at comparable densities at both the animal and vegetal hemispheres of the cell. Rare (variant) donors possess oocytes that express mainly M1-like receptors (M1Rs), localized predominantly at the animal hemisphere. We have investigated the apparent degradation of these two isoforms and its relationship to their hemispheric distribution. Cycloheximide (CHX) caused a time-dependent decrease in receptor-mediated responses and [3H]quinuclidinyl benzylate (QNB) binding in oocytes from both types of donors. The t1/2 values ranged between 3 and 7 h. Removal of CHX resulted in rapid recovery of the response. This implied rapid degradation and turnover of both types of receptors. The loss of M1Rs was more than that of M3Rs. Moreover, the decrease was more rapid and more extensive on the animal hemisphere in both types of donors. Injection of oocytes expressing either receptor isoform with specific antisense oligonucleotides complementary to either m1 or m3 muscarinic receptors (from mouse) showed receptor loss at approximately the same rate as that calculated from experiments with CHX. Furthermore, oocytes of variant donors express M1Rs exclusively on the animal hemisphere, while the residual activity found on the vegetal hemisphere of the cell was mediated by M3Rs. Inhibition of putative receptor glycosylation with tunicamycin caused a rapid decrease in receptor-mediated responses and radioligand binding on M1Rs, but had virtually no effect on M3Rs. The expression of cloned m1 muscarinic receptors, however, was not affected by tunicamycin, suggesting that glycosylation is not a general prerequisite for the functional expression of muscarinic receptors.
Bar-Sagi,
Tunicamycin inhibits the expression of surface Na+ channels in cultured muscle cells.
1983, Pubmed
Bar-Sagi,
Tunicamycin inhibits the expression of surface Na+ channels in cultured muscle cells.
1983,
Pubmed
Bonner,
Identification of a family of muscarinic acetylcholine receptor genes.
1987,
Pubmed
Cavalieri,
Induction and decay of human fibroblast interferon mRNA.
1977,
Pubmed
,
Xenbase
Dascal,
The use of Xenopus oocytes for the study of ion channels.
1987,
Pubmed
,
Xenbase
Davidson,
Native Xenopus oocytes express two types of muscarinic receptors.
1991,
Pubmed
,
Xenbase
Duksin,
Relationship of the structure and biological activity of the natural homologues of tunicamycin.
1982,
Pubmed
Dumont,
Oogenesis in Xenopus laevis (Daudin). I. Stages of oocyte development in laboratory maintained animals.
1972,
Pubmed
,
Xenbase
Liao,
Molecular cloning and expression of a fifth muscarinic acetylcholine receptor.
1989,
Pubmed
Liles,
Regulation of neuronal muscarinic acetylcholine receptor number by protein glycosylation.
1986,
Pubmed
Lupu-Meiri,
Two types of intrinsic muscarinic responses in Xenopus oocytes. I. Differences in latencies and 45Ca efflux kinetics.
1990,
Pubmed
,
Xenbase
Matus-Leibovitch,
Two types of intrinsic muscarinic responses in Xenopus oocytes. II. Hemispheric asymmetry of responses and receptor distribution.
1990,
Pubmed
,
Xenbase
Mishina,
Location of functional regions of acetylcholine receptor alpha-subunit by site-directed mutagenesis.
,
Pubmed
,
Xenbase
Nadler,
Acetylcholine- and inositol 1,4,5-trisphosphate-induced calcium mobilization in Xenopus laevis oocytes.
1986,
Pubmed
,
Xenbase
Oron,
Differences in receptor-evoked membrane electrical responses in native and mRNA-injected Xenopus oocytes.
1988,
Pubmed
,
Xenbase
Oron,
The Xenopus oocyte--a model system for lipid-mediated activation of neurotransmitter receptors.
1985,
Pubmed
,
Xenbase
Oron,
Mechanism of membrane electrical response to thyrotropin-releasing hormone in Xenopus oocytes injected with GH3 pituitary cell messenger ribonucleic acid.
1987,
Pubmed
,
Xenbase
Pitta,
A single-amino-acid substitution eliminates the stringent carbohydrate requirement for intracellular transport of a viral glycoprotein.
1989,
Pubmed
Prives,
Carbohydrate requirement for expression and stability of acetylcholine receptor on the surface of embryonic muscle cells in culture.
1980,
Pubmed
Richter,
Adenovirus E1A requires synthesis of a cellular protein to establish a stable transcription complex in injected Xenopus laevis oocytes.
1987,
Pubmed
,
Xenbase
Soreq,
The biosynthesis of biologically active proteins in mRNA-microinjected Xenopus oocytes.
1985,
Pubmed
,
Xenbase
Straub,
Receptor number determines latency and amplitude of the thyrotropin-releasing hormone response in Xenopus oocytes injected with pituitary RNA.
1989,
Pubmed
,
Xenbase
Sumikawa,
Assembly and N-glycosylation of all ACh receptor subunits are required for their efficient insertion into plasma membranes.
1989,
Pubmed
,
Xenbase
Sumikawa,
Effect of tunicamycin on the expression of functional brain neurotransmitter receptors and voltage-operated channels in Xenopus oocytes.
1988,
Pubmed
,
Xenbase
van Koppen,
Site-directed mutagenesis of the m2 muscarinic acetylcholine receptor. Analysis of the role of N-glycosylation in receptor expression and function.
1990,
Pubmed
Vilaró,
Muscarinic cholinergic receptors in the rat caudate-putamen and olfactory tubercle belong predominantly to the m4 class: in situ hybridization and receptor autoradiography evidence.
1991,
Pubmed